Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Restless Legs Syndrome
NCT00621517Phase 3Completed
- Sponsor
- East Tennessee State University
- Start
- Feb 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in restless legs syndrome (RLS) comparing Bupropion with Placebo (2 arms). Primary endpoints: International Restless Legs Syndrome Study Group Severity Scale at 6 weeks, Clinical Global Impression - Improvement Scale at 6 weeks and 1 more. Started Feb 2008; status: completed.
02
Drugs
bupropion
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00621517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621517.